Radar Healthcare, a provider of digital risk management and quality compliance software, is excited to announce a strategic investment in EIDO Healthcare (“EIDO”), a leading provider of digital consent and patient information solutions. Together, these two established providers of healthcare solutions will combine their expertise to deliver high-quality tools for organisations across the health and care landscape, supporting safer and more effective care.

Radar, Marlin and EIDO logos

This exciting development brings together two highly complementary organisations with decades of knowledge and a shared vision for driving positive change in healthcare. By uniting Radar Healthcare’s innovative technology and EIDO’s trusted informed consent solutions, the combined organisation is poised to accelerate growth and enhance its offering for customers in the health and care markets across the globe.

“This is an exciting new chapter for Radar Healthcare,” said Paul Johnson, CEO of Radar Healthcare. “We are thrilled to have EIDO joining us to grow our ecosystem and enhance what we can offer to healthcare and care providers. Both organisations share a deep passion for improving healthcare, and together, we can address new challenges while continuing to deliver exceptional service and innovation to our customers.”

The combination will enable broader functionality, deeper technical expertise, and more opportunities for healthcare and care teams to improve outcomes. Reflecting a commitment to customer-centric innovation, Radar Healthcare and EIDO will also engage with healthcare providers through customer forums, ensuring their feedback shapes future developments and supports the delivery of intuitive, impactful solutions.

“At EIDO, we are proud of our long-standing reputation for providing trusted patient information solutions,” said Matthew Ravenscroft, CEO of EIDO. “This strategic investment from Radar Healthcare allows us to build on this legacy, combining our strengths to better support healthcare providers and empower patients with clear, reliable information. This will allow us to enhance digital consent processes through our suite of resources designed to support healthcare professionals and reduce the risk of litigation as well as enhance the patient experience. We look forward to embarking on this transformative journey together.”

This news follows a significant investment in Radar Healthcare last year from Marlin Equity Partners, which backed the company to accelerate growth and expand its product offering. The integration with EIDO is another step forward in driving innovation within healthcare, and both companies are committed to delivering exceptional value to their customers.

“We are excited to work alongside EIDO following the strategic investment from Radar Healthcare. Both organisations have a proven commitment to excellence and are united in their passion to offer their customers the best possible digital solutions to achieve their goals.”

Chris Clasper, a principal at Marlin.

Further updates about this partnership and its benefits for customers will be shared in the coming months.

About Radar Healthcare
Radar Healthcare empowers health and social care organisations to make a meaningful impact on patient safety and quality of care. By blending digital innovation with real-world healthcare expertise, Radar Healthcare enables providers to not only meet regulatory standards but to actively spot trends, prevent incidents, and drive continuous improvement. Designed with flexibility and adaptability in mind, and with a deep understanding of the daily challenges in health and care, Radar Healthcare is dedicated to evolving alongside the industry, delivering a system that is valued for its role in shaping safer, more effective care. For more information, please visit radarhealthcare.com.

About EIDO Healthcare
EIDO is a trusted provider of digital consent and patient information solutions, specialising in creating clear, accurate, and accessible content to support informed consent in healthcare. With decades of experience, EIDO helps healthcare providers deliver safe, effective care by ensuring patients have the information they need to make well-informed decisions about their treatment. The modular digital informed consent solution supports deployment into the patient pathway, either as standalone modules or as a complete solution. Known for its commitment to quality and innovation, EIDO works with healthcare organisations globally to empower both patients and clinicians in achieving better outcomes. For more information, please visit eidohealthcare.com.

About Marlin Equity Partners
Marlin Equity Partners is a global investment firm with over $9 billion in capital commitments. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company’s outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 250 acquisitions. The firm is headquartered in Los Angeles, California, with an additional office in London. For more information, please visit marlinequity.com.